[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
January 1993

Impaired Polymorphonuclear Leukocyte Anticandidal Function in Injured Adults With Elevated Candida Antigen Titers

Author Affiliations

From the Departments of Surgery (Drs Sweeney and Rosemurgy) and Immunology and Medical Microbiology (Drs Wei and Djeu), University of South Florida College of Medicine, and the Immunology Program H. Lee Moffitt Cancer Center (Drs Wei and Djeu), Tampa, Fla.

Arch Surg. 1993;128(1):40-46. doi:10.1001/archsurg.1993.01420130044008
Abstract

• Per protocol, adults with an Injury Severity Score of 18 or greater underwent Candida antigen titer measurements weekly. If titers were 1:4 or greater, neutrophil function against Candida albicans was determined with use of a tritiated glucose incorporation assay, and polymorphonuclear leukocytes obtained from healthy blood donors were studied concurrently for comparison. Polymorphonuclear leukocytes from healthy blood donors and injured patients with elevated titers were able to inhibit C albicans growth in a dose-dependent fashion. Polymorphonuclear leukocytes from injured patients with elevated titers had a significantly depressed ability to inhibit C albicans growth compared with those from healthy blood donors at all effector cell—to—target cell ratios tested. Cytokine-treated polymorphonuclear leukocytes from healthy blood donors and injured patients with elevated Candida antigen titers demonstrated significantly improved anticandidal activity at all ratios of polymorphonuclear leukocytes—to–Candida. Granulocyte macrophage—colony stimulating factor was the most potent cytokine at reconstituting polymorphonuclear leukocyte function, followed by interferon gamma and interleukin 8. In conclusion, an elevated Candida antigen titer in injured adults is associated with impaired polymorphonuclear leukocyte antifungal activity. This depressed activity can be reconstituted by the addition of cytokine.

(Arch Surg. 1993;128:40-46)

References
1.
Faist E, Mewes A, Strasser T, et al.  Alteration of monocyte function following major injury . Arch Surg . 1988;123:287-292.Article
2.
Rosemurgy AS, Hart MB, Murphy CG, et al.  Infection after injury: association with blood transfusion . Am Surg . 1992;58:104-107.
3.
Spebar MJ, Pruitt BA Jr.  Candidiasis in the burn patient . J Trauma . 1981;21:237-239.Article
4.
MacMillan BG, Law EJ, Holder IA.  Experience with Candida infections in the burn patient . Arch Surg . 1972;104:509-514.Article
5.
DeLozier JB, Stratton CW, Potts JR.  Rapid diagnosis of Candida sepsis in surgical patients . Am Surg . 1987;53:600-602.
6.
Marsh PK, Tally FP, Kellum J, Callow A, Gorbach SL.  Candida infections in surgical patients . Ann Surg . 1983;198:42-47.Article
7.
Odds FC. Candida and Candidiasis: A Review and Bibliography . 2nd ed. Philadelphia, Pa: WB Saunders Co; 1988.
8.
Diamond RD, Clark RA, Haudenschild CC.  Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro . J Clin Invest . 1980;66:908-917.Article
9.
Schuit KE.  Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils . Infect Immun . 1979;24:932-938.
10.
Babior BM.  Oxygen-dependent microbial killing by phagocytes . N Engl J Med . 1978;298:659-668.Article
11.
Clark RA.  The human neutrophil respiratory burst oxidase . J Infect Dis . 1990;161:1140-1147.Article
12.
Spitznagel JK.  Nonoxidative antimicrobial reactions of leukocytes . Contemp Top Immunobiol . 1986;14:283-343.
13.
Bach MC, Sahyoun A, Adler JL, et al.  High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression . Transplant Proc . 1973;5:549-553.
14.
Cho YS, Choi HY.  Opportunistic fungal infection among cancer patients: a ten year autopsy study . Am J Clin Pathol . 1979;72:617-621.
15.
Mildvan D, Mathur U, Enlow RW, et al.  Opportunistic infections and immune deficiency in homosexual men . Ann Intern Med . 1982;96:700-704.Article
16.
Sugar AM.  Problems in the diagnosis of invasive candidiasis in the immunocompromised host . In: Richardson RG, ed. Opportunistic Fungal Infections: Focus on Fluconazole . Royal Society of Medicine Services International Congress and Symposium Series No. (153) . 1989, Royal Society of Medicine Services Limited.
17.
Bodey GP.  Candidiasis in cancer patients . Am J Med . 1984;74:13-19.
18.
Maksymuik AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP.  Systemic candidiasis in cancer patients . Am J Med . 1984;74:20-27.
19.
Myerwitz RL, Pazin GJ, Allen CM.  Disseminated candidiasis: changes in incidence, underlying diseases, and pathology . Am J Clin Pathol . 1977;68:29-38.
20.
Horn R, Wong B, Kiehn TE, Armstrong D.  Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy . Rev Infect Dis . 1985;7:646-655.Article
21.
Kahn FW, Jones JM.  Latex agglutination tests for detection of Candida antigens in sera of patients with invasive candidiasis . J Infect Dis . 1986;153: 579-585.Article
22.
Piens MA, Guyotat D, Archimbaud E, et al.  Evaluation of a Candida antigen detection test (CAND-TEC) in the diagnosis of deep candidiasis in neutropenic patients . Eur J Cancer Clin Oncol . 1988;24:1655-1659.Article
23.
Escuro RS, Jacobs M, Gerson SL.  Prospective evaluation of a Candida antigen detection test for invasive candidiasis in immunocompromised adult patients with cancer . Am J Med . 1989;81:621-627.Article
24.
Rosemurgy AS, Drost TF, Murphy CG, Kearney RE, Albrink MA.  Treatment of candidosis in severely injured adults with short course low-dose amphotericin B . J Trauma . 1990;30:1521-1523.Article
25.
Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK.  Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8 . J Immunol . 1990;144:2205-2210.
26.
Djeu JY, Parapanissios A, Halkais D, Friedman H.  A rapid 3 H glucose incorporation assay for determination of lymphoid cell-mediated inhibition of C. albicans growth . J Immunol Methods . 1986;92:73-77.Article
27.
Blanchard DK, Michelini-Norris MD, Djeu JY.  Production of granulocyte-macrophage colony stimulating factor by large granular lymphocytes: role in activation of human neutrophil function . Blood . 1991;77: 2259-2265.
28.
Djeu JY, Blanchard DK, Halkias D, Friedman H.  Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon- and tumor necrosis factor . J Immunol . 1986;137:2980-2984.
29.
Gasson JC, Weisbart RH, Kaufman SE, et al.  Purified human granulocyte macrophage-colony stimulating factor: direct action on neutrophils . Science . 1984;226:1339-1342.Article
30.
Yoshimura T, Matsushima K, Tanaka S, et al.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines . Proc Natl Acad Sci U S A . 1987; 84:9233-9237.Article
31.
Perussia B, Kobayashi M, Rossi ME, Anegon I, Trinchieri G.  Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony stimulating factor . J Immunol . 1987;138:765-774.
32.
Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator . Nature . 1985;314:361-363.Article
33.
Abbas AK, Lichtman AH, Pober JS.  Cytokines . Cellular and Molecular Immunology . Philadelphia, Pa: WB Saunders Co; 1991.
34.
Bjerknes R, Vindenes H, Laerum OD.  Altered neutrophil function in patients with large burns . Blood Cells . 1990;16:127-143.
35.
Grogan JB, Miller RC.  Impaired polymorphonuclear leukocytes in patients with burns and other trauma . Surg Gynecol Obstet . 1973;137:784-793.
×